Literature DB >> 18298791

Protein tyrosine phosphatases: regulatory mechanisms.

Jeroen den Hertog1, Arne Ostman, Frank-D Böhmer.   

Abstract

Protein-tyrosine phosphatases are tightly controlled by various mechanisms, ranging from differential expression in specific cell types to restricted subcellular localization, limited proteolysis, post-translational modifications affecting intrinsic catalytic activity, ligand binding and dimerization. Here, we review the regulatory mechanisms found to control the classical protein-tyrosine phosphatases.

Mesh:

Substances:

Year:  2008        PMID: 18298791     DOI: 10.1111/j.1742-4658.2008.06247.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  41 in total

1.  Hormetic signaling patterns.

Authors:  Reinhard Wetzker; Ignacio Rubio
Journal:  Dose Response       Date:  2011-10-14       Impact factor: 2.658

2.  Oxidative stress-induced oligomerization inhibits the activity of the non-receptor tyrosine phosphatase STEP61.

Authors:  Ishani Deb; Ranjana Poddar; Surojit Paul
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

Review 3.  Novel Ser/Thr protein phosphatases in cell death regulation.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Physiology (Bethesda)       Date:  2012-02

Review 4.  Cellular biochemistry methods for investigating protein tyrosine phosphatases.

Authors:  Stephanie M Stanford; Vanessa Ahmed; Amy M Barrios; Nunzio Bottini
Journal:  Antioxid Redox Signal       Date:  2014-02-25       Impact factor: 8.401

Review 5.  Mining the function of protein tyrosine phosphatases in health and disease.

Authors:  Hojin Lee; Jae-Sung Yi; Ahmed Lawan; Kisuk Min; Anton M Bennett
Journal:  Semin Cell Dev Biol       Date:  2014-09-26       Impact factor: 7.727

Review 6.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

7.  Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.

Authors:  Fatiha Tabet; Ernesto L Schiffrin; Glaucia E Callera; Ying He; Guoying Yao; Arne Ostman; Kai Kappert; Nicholas K Tonks; Rhian M Touyz
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

8.  The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages.

Authors:  Amanda E Lane; Joanne T M Tan; Clare L Hawkins; Alison K Heather; Michael J Davies
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

Review 9.  PTPRR protein tyrosine phosphatase isoforms and locomotion of vesicles and mice.

Authors:  Wiljan J A J Hendriks; Gönül Dilaver; Yvet E Noordman; Berry Kremer; Jack A M Fransen
Journal:  Cerebellum       Date:  2009-01-10       Impact factor: 3.847

Review 10.  ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside.

Authors:  Jianbiao Zhou; Boon-Cher Goh; Daniel H Albert; Chien-Shing Chen
Journal:  J Hematol Oncol       Date:  2009-07-30       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.